Posted by Michael Wonder on 30 Aug 2016
Agenda for the 7 September 2016 TC meeting
30 August 2016 - The Transparency Commission will reconvene early next month after the summer break to review a few new medicines.
The Commission will review the reimbursement of Cyramza (ramucirumab), Levemir (insulin detemir) and Ionsys (fentanyl).
